Comprehensive Analysis Based on the Cancer-Immunity Cycle Identifies a Novel Immunosuppressive Subtype of Bladder Cancer. [PDF]
Deng Z, Li Y, Shen Y, Zhou M.
europepmc +1 more source
Identification of MYC co-expression gene: POLR3G is associated with cell senescence, immunotherapy, chemotherapy responses, and clinical prognosis in bladder cancer patients. [PDF]
Zhu L +7 more
europepmc +1 more source
A five-gene mitochondria-associated prognostic signature for bladder cancer. [PDF]
Liu J +7 more
europepmc +1 more source
Development and validation of an interpretable prognostic model for bladder cancer based on lactylation associated genes using SHAP analysis. [PDF]
Wang Y, Yu X.
europepmc +1 more source
Machine learning-based integration identifies lactylation biomarkers for prognosis prediction and tumor microenvironment modulation in bladder cancer. [PDF]
Zhou X +8 more
europepmc +1 more source
Ribosome biogenesis programs define a three-gene RBscore with prognostic relevance in bladder cancer. [PDF]
Luo G +9 more
europepmc +1 more source
Integrate single-cell and transcriptome analyses to explore the prognostic genes related to TRPM4 in bladder cancer. [PDF]
Zhao Q +6 more
europepmc +1 more source
NT5DC2 inhibits ferroptosis by stabilizing ACSL3 in bladder cancer. [PDF]
Niu S +12 more
europepmc +1 more source
Overexpression of MFAP4 inhibits the proliferation, migration, and invasion of bladder cancer cells. [PDF]
Zhang W, Dai L, Luo M, Shi H.
europepmc +1 more source
Comprehensive Genomic Characterization Between Urothelial Carcinoma Subtypes/Divergent Differentiation (S/DD) and Pure Urothelial Carcinoma Using a Large-Scale Japanese Genomic Panel Dataset. [PDF]
Kobayashi G +10 more
europepmc +1 more source

